Article
Characterization of a Novel Pathogen in Immunocompromised Patients:Elizabethkingia anophelis—Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and β-lactamase Inhibitors
31 Jan 2023
Abstract excerpt
Abstract Background Elizabethkingia anophelis is an emerging Gram-negative nonlactose fermenter in the health care setting, where it causes life-threatening infections in immunocompromised patients. We aimed to characterize the molecular mechanisms of antimicrobial resistance and evaluate the utility of contemporary antibiotics with the intent to offer targeted therapy against an uncommonly encountered pathogen....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
